top of page

Evaluation of existing CPGs for rare cancer subtypes

Appraisal Tool

  • Assess the accessibility of existing CPGs (online and printed versions) and the degree of updating of CPGs

  • Assess the validation process of guidelines and the contribution of partners

  • Score the CPGs according to available quality criteria

Appraisal Tool: Mix Methods

  • Using of Cluzeau instrument with 19 sample questions (Evaluation Criteria)

  • Using of the international Centre for Allied Health Evidence (iCAHE) instrument for scoring (binary scored instrument) => appraisal score calculation

  • Multiple choice answer, mostly the “yes/no” score

  • =>Yes=1; No=0

 

537 guidelines produced by different medical databases and European cancer societies were identified and collected. Documents that did not contain recommendations and/or evidence based clinical practice were exclude, so 257 guidelines fulfilled the inclusion criteria. After the screening process 48% of the collected guidelines were included in the quality evaluation.

Bild1.png

Guidelines collected

Bild2.png
Unbenannt.JPG

Work Package 6

_project_management_standards.jpg
bottom of page